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■ LETTER TO THE EDITOR ■
When a woman presents with a solid tumor in the pelvis
and abdominal wall and an increased level of CA125,
malignancy is always diagnosed first. If the patient also
has signs of inflammation, such as fever and increased
levels of white blood cell (WBC) and C-reactive pro-
tein, the findings are mostly attributed to necrosis of
the tumor. In this article, we present a patient with a
tumor in the cul-de-sac and another in the lower
abdominal wall below the navel that was misdiag-
nosed with malignancy but was eventually cured using
medication.
A 41-year-old woman, gravida 2, para 2, was admit-
ted to our hospital, because she had experienced lower
abdominal pain and fever for 3 months. Prior to hospi-
talization, she had been in good health, and her men-
struation had been normal. She had not traveled abroad
or kept any pets in that recent period. The symptoms sub-
sided and relapsed repeatedly. Body temperature was
sometimes above 38°C. Her condition did not improve,
although she had been seeing a medical practitioner.
The patient was thin, short, and mentally sound and
did not look very sick. She admitted having an intrauter-
ine device (IUD) implanted 14 years prior to admission.
Her body temperature was 37°C and pulse rate was
76/minute. Gynecologic examination revealed the fol-
lowing: no abnormal vaginal discharge, normal looking
cervix with no tender points, an IUD implanted in the
uterus, flat and soft abdomen that demonstrated no
tenderness or rebound pain upon palpation. The pos-
terior wall of the cervix and the abdominal wall below
the navel each had a fist-sized tumor. Digital anal exami-
nation showed that the tumor in the cul-de-sac
(rectouterine pouch) was hard.
Laboratory test results revealed the following:
WBC, 23,900/mm3; hemoglobin, 9.6 g/dL; mean cor-
puscular volume, 89.4 fL; C-reactive protein, 19.5mg/dL;
erythrocyte sedimentation rate (ESR), 121 mm/h and
128 mm/2 h. Liver function and renal function tests were
normal, and electrolyte levels were normal. With regards
to the tumor markers, CA125 increased to 135.7 IU/mL,
α-fetoprotein was 1.2 ng/mL, squamous cell anti-
gen of the cervix was 0.1 ng/mL, β-human chorionic
gonadotropin was 0.1 mIU/mL, lactate dehydrogenase
was 261 IU/L. All of the results were within the refer-
ence ranges. Ultrasonic examination results revealed
that both the cervix and the uterine body were normal;
however, between the posterior wall of the uterus and
the rectum, as well as beneath the lower abdominal
wall below the navel, two tumors, 7 cm in size, round
and solid with irregular margins, were found, respec-
tively (Figures 1 and 2). Ultrasonic examination results
also revealed that the ovaries were normal. Again, com-
puted tomography (CT) scan confirmed that between
the posterior wall of the uterus and the rectum was a
tumor, 8 × 7 × 6.8 cm, with a blurred and irregular
margin, solid, and uneven density (Figures 3 and 4),
AN UNCOMMON CASE OF PELVIC AND ABDOMINAL
WALL MASS: PRESUMED PELVIC ACTINOMYCOSIS
Tien-Lung Ko, Yiu-Tai Li1*, Yi-Chih Chu1, Tien-Hui Chen1, Chin-Sheng Chen2,
Fu-Min Chen3, Tsung-Cheng Kuo1
Departments of Radiology, 1Obstetrics and Gynecology, and 2Gastroenterology, Kuo General Hospital, 
Tainan, and 3Department of Obstetrics and Gynecology, Chung Shan Hospital, Taipei, Taiwan.
*Correspondence to: Dr Yiu-Tai Li, Department of Obstetrics and
Gynecology, Kuo General Hospital, 22, Ming-Sheng Road,
Section 2, Tainan 700, Taiwan.
E-mail: drgynobs@yam.com
Accepted: April 4, 2007
Figure 1. Abdominal sonography showing a solid mass (M)
beneath the umbilical area (U).
and lying under the lower abdominal wall below the
navel was a similar tumor with the dimensions of
6 × 5 × 5 cm. The radiologist diagnosed the patient with
cervical cancer with distal metastasis. The surgeon diag-
nosed the patient with rectal cancer with metastasis and
suggested excision.
The patient’s Papanicolaou (Pap) smear results re-
vealed no cancer cells or germs. After removal of the IUD,
the result of endometrial bacterial culture was negative
and that of vaginal bacterial culture revealed only the
presence of E. coli. Endometrial examination did not
reveal sulfur granules. No sample was obtained under
ultrasonography-guided fine-needle puncture of the
cul-de-sac or the lower abdominal wall. Rectoscopy
revealed tumor compression of the anterior wall of the
rectum at a position corresponding to the cervix.
The patient was treated with intravenous 3.0 g
Unasyn (ampicillin/sulbactam) q6h, 80 mg gentamycin
q12h, and 500 mg metronidazole q6h, and alleviation
of symptoms occurred within 2 days of beginning
treatment. Seven days after beginning treatment, both
tumors shrank to half of their former sizes, whereas WBC
count and levels of C-reactive protein and ESR returned
to normal. After being discharged from the hospital, the
patient continued the oral administration of ampicillin
and metronidazole. Six weeks after beginning treat-
ment, neither tumor was palpable nor could they be
observed using CT scan (Figures 5 and 6). In addition,
the CA125 level and other blood test results were nor-
mal. The patient continued the oral administration of
ampicillin for 3 months. No abnormalities were found
at the 6-month follow-up consultation.
The patient’s chief complaint was lower abdominal
pain and fever. Laboratory test results revealed increased
WBC count and levels of C-reactive protein and ESR.
The discovery of tumors characterized by irregular mar-
gins, which were located at the pelvic cavity and under-
neath the abdominal wall, coupled with a 14-year use
of an IUD, led to the diagnosis of actinomycosis, an
abscess caused by Actinomyces infection. The symptoms
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Figure 2. Pelvic sonography showing a complex mass (M)
behind the uterus (Ut).
Figure 3. Computed tomogram showing a 6-cm tumor mass
(M) beneath the umbilical area (U).
Figure 4. Computed tomogram showing an 8-cm irregular
and poorly defined mass (M) behind the uterus (Ut).
Figure 5. Six weeks after beginning treatment, computed
tomography showed that the tumor mass had disappeared
completely beneath the umbilical area (U).
were effectively alleviated with high doses of antibiotics.
Although actinomycosis was not proved by pathologic
examination such as Pap smear or endometrial pathol-
ogy, actinomycosis abscess was suggested by the clini-
cal findings. Lee et al [1] suggested the application of
transcutaneous CT-guided needle biopsy to establish
the diagnosis of pelvic actinomycosis. However, we failed
to obtain a sample under ultrasonography-guided fine-
needle puncture of the cul-de-sac and the lower
abdominal wall.
Normally, Actinomyces are present in the oral cavity
and the tonsils. They are not pathogenic even when swal-
lowed and end up in the gastrointestinal tract. However,
Actinomyces can enter the pelvis and cause infection,
resulting in actinomycosis. Major pathogenic Actinomyces
for human beings is Actinomyces israelii. Most patients
with Actinomyces-induced pelvic inflammation have a
history of IUD use. IUD-induced inflammation of the
endometrium is not uncommon. Reportedly, A. israelii
is present in the reproductive tract of 1.6–44% of IUD
users (8–16% is suggested in most reports) [2,3], and
the incidence rises slightly after 2 years of IUD use. In
this study, the patient had used an IUD for 14 years.
Occasionally, Actinomyces have been found in the vaginas
of women with IUD, but the significance is unclear [4].
Actinomyces-induced pelvic inflammation is accom-
panied by symptoms such as general malaise, fever,
loss of appetite, weight loss, lower abdominal pain, vagi-
nal bleeding, and vaginal discharge. Symptoms are
classified into three categories, namely acute, suba-
cute, and chronic. Physical examination usually reveals
a large, immobile tumor found near a reproductive
organ and the tissue surrounding the uterus character-
ized by fibrosis and enlargement, thus suggesting a
female cancer. Around 90% of patients diagnosed with
unilateral or bilateral tubo-ovarian abscesses might
have the abscess invading the ureters, large intestine,
or small intestine, causing renal/urinary tract disten-
tion, hydronephrosis, or topical intestinal obstruction.
Symptoms include vomiting, constipation, bowel dis-
tention, and lumbago. Invasion into the urinary blad-
der may result in pain on urination, whereas invasion
into the posterior peritoneum may result in posterior
peritoneum fibrosis. The mildest scenario involves only
endometritis. In a few cases, the abscess finds its way
to the skin through a sinus tract; in this case, the
patient’s hypodermal mass was attributed to bacteria
having escaped to the hypoderm.
Typical findings of laboratory test results comprised
of increased WBC count, anemia, increased levels of
ESR, C-reactive protein, CA125 and CA199. In the event
of severe hydronephrosis, the renal function deteriorates
(as substantiated by increased serum potassium, blood
urea nitrogen and creatinine). The patient described in
this article also showed increased WBC count and ane-
mia, as well as increased levels of ESR, C-reactive pro-
tein and CA125.
Ultrasonic examination usually reveals an IUD inside
the uterus and a pelvic tumor having an irregular mar-
gin due to hypertrophy and fibrosis, wherein the lesion
is solid and characterized by the presence of gas or 
an abscess. CT scan reveals that Actinomyces-induced
pelvic inflammation mostly manifests in the form of 
a solid tumor with topical image attenuation or in 
the form of a sclerosed cystic tumor. Upon injection 
of contrast medium, 80% of the solid lesions show
uneven density, which is displayed with enhancement
[5]. In our case, the CT scan revealed that the margins
of the tumor were poorly defined and that the density
of the tumor was uneven, suggesting the image of an
infectious tumor.
In Taiwan, Hu et al [6] reported a case where a 
29-year-old woman with 3 years of IUD use received
surgery on a 12-cm tumor in the pelvis. During the 
surgery, rectal perforation occurred because of severe
adhesion, and the patient ended up having an artificial
anus constructed. Upon frozen section examination, she
was diagnosed with actinomycosis. She recovered from
the inflammation after being treated with penicillin for
6 months, and then she had her intestine repaired. Lo
et al [7] reported a case where a 46-year-old woman
with 15 years of IUD use was found to have a 6-cm solid
tumor between the uterus and the urinary bladder, and
an adnexal mass on the right side was a 4-cm tumor
with multiple septa. Before the surgery, the patient was
diagnosed with pelvic malignancy. During the surgery,
the surgeon discovered severe adhesion of the great
omentum and pelvic organs. During the operation con-
sisting of hysterectomy, bilateral oophorectomy, bilateral
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Figure 6. Six weeks after beginning treatment, computed
tomography showed that the tumor mass had disappeared
completely between the uterus (Ut) and rectum (R).
salpingectomy, and excision of the great omentum, the
urinary bladder was pierced while the adhesion was
being separated. As a result, the pierced urinary bladder
was sutured, and suprapubic drainage of the urinary
bladder was performed. Finally, pathologic examination
revealed Actinomyces infection, and the patient was even-
tually cured using a combination of antibiotics. Tzeng
et al [8] reported a case where a 55-year-old woman
was admitted to the hospital because of weight loss and
appetite loss. The patient had used an IUD for 15 years.
Her WBC count was 15,600/mm3, and CT scan revealed
a 7-cm tumor in the lower left abdomen. Before the sur-
gery, the patient was diagnosed with rectal cancer.
During the surgery, the lower left abdomen was found
to have a tumor that invaded into the descending colon,
left ovary, and uterus. Upon frozen section examination,
she was diagnosed with Actinomyces-induced abscess.
Owing to the imminent perforation of the colon, a 36-cm
section of the colon was excised, and she received a
Hartmann operation, total hysterectomy, bilateral
oophorectomy, and bilateral salpingectomy. After the
surgery, she was treated with clindamycin, and no
abnormalities were found at the 5-month follow-up
consultation. In Taiwan, almost all of the diagnoses of
abdominopelvic actinomycosis were made during exten-
sive surgical exploration (Table). With regard to the
aforesaid three cases, if there had been accurate pre-
operative diagnoses, the uterus and the ovaries would
had been spared, not to mention that the intestine and
the urinary bladder would had been free of surgical
wounds.
There is great difficulty during surgery for treating
Actinomyces-induced abscesses. The abscesses mostly
have hard external layers characterized by fibrosis,
which are described as “woody induration”, and often
invade the pelvic organs like the intestines and the
ureters. As a result, surgical planes between different
tissues disappear, and thus the organs are very likely to
be injured during surgery. Hence, the patients have 
to receive remedial surgery, such as colostomy, in order
to have a temporary artificial anus, which affects the
patients’ quality of life to a great extent. In particular,
insomuch as Actinomyces infection can be effectively
treated using penicillin, a patient diagnosed with
Actinomyces infection may choose to take medicine for
2 to 3 days and proceed to surgery only after medica-
tion proves futile or when the illness causes deteriora-
tion. In the present case, the patient was treated with
penicillin and therefore recovered quickly, without the
need for any diagnostic and therapeutic surgery. Actino-
mycosis is frequently accompanied by Gram-negative
and anaerobic bacteria; thus, in addition to penicillin,
the patients are treated using antibiotics other than
penicillin. Tetracycline, erythromycin, and clindamycin
appear to be acceptable alternatives to penicillin;
cephalosporins, aminoglycosides, ciprofloxacin, and
metronidazole have also been used as adjunctive ther-
apeutics. Usually, the researchers recommend antibiotic
therapy for 6–12 months in those with pelvic actinomy-
cosis. Atad et al [9] proposed that if the abscess can be
completely removed surgically, a shorter period (≤ 3
months) of antibiotic therapy could be effective.
Although Actinomyces-induced pelvic abscesses are
rare, they can be fatal. In practice, actinomycosis is
manifested by a wide variety of lesions, namely pelvic
abscess, ureter distention, hydronephrosis, vesicouterine
fistula, ileus, appendicitis, gastric perforation, fibrosis of
posterior abdominal wall, and abscess at the abdominal
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Table. Summary of reported Taiwanese cases of pelvic actinomycosis
Author Year Age (years) IUD Preoperative diagnosis Treatment modalities Complications
Hsu et al [22] 1990 35 (+) Pelvic abscess ATH + BSO –
52 (+) Myoma uteri ATH + BSO –
48 (+) Pelvic abscess ATH + BSO –
41 (+) Myoma uteri ATH + BSO Enterocutaneous
fistula
27 (+) Pelvic abscess ATH + BSO –
40 (+) Pelvic abscess ATH + BSO –
Chang et al [23] 1996 44 (+) Bilateral ovarian tumors ATH + BSO –
Lo et al [7] 1997 46 (+) Genital or urologic cancer ATH + BSO + partial Urinary bladder 
omentectomy perforation
Lee et al [1] 2000 38 (+) Ovarian cancer Cytoreductive surgery –
Tzeng et al [8] 2004 55 (+) Rectal cancer ATH + BSO + Hartmann Colon perforation
operation
Hu et al [6] 2005 29 (+) Ovarian cancer Extensive tumor excision Rectal perforation
IUD = intrauterine device; (+) = present; ATH = abdominal total hysterectomy; BSO = bilateral salpingo-oophorectomy.
wall. Thus, actinomycosis is similar to women’s cancer
in terms of symptoms and imaging findings [9–16]. If a
patient is implanted with an IUD, the pathologist should
attach great importance to Pap smears and endome-
trial examination. In addition, needle puncture of the
alleged pelvic tumor should be performed in order to
rule out actinomycosis. If the actinomycosis is not dis-
covered until during surgery, the diagnosis should be
proved using frozen section examination. A word of cau-
tion: in order to avoid complications, we recommend
that difficult operations should not be attempted.
In the present case, all the clinical findings, CT scan,
and laboratory findings were normal within 6 weeks
after beginning treatment. Accordingly, the patient was
conclusively diagnosed with infectious abscesses. Prior
to the confirmation of the diagnosis, there should be
differential diagnosis against abdominal tuberculosis
[17], deep infiltrating endometriosis [18], rectal cancer
[8], ovarian cancer [1], and other malignancies [19–21].
All the aforesaid diseases can cause abdominal tumors,
increased WBC count, and increased levels of C-reactive
protein, ESR or CA125; but all of them require a laparo-
scopy or explorative laparotomy to obtain a pathologic
specimen for diagnosis. In the present case, there was a
history of IUD use; thus, actinomycosis was not ruled
out, and the lesion was eliminated using antibiotics.
Despite a lack of pathologic evidence, the present case
is rare, and its clinical findings are valuable, giving
proof of the important role of a therapeutic diagnosis.
Actinomycosis has been called “the most misdiagnosed
disease”, and it has been said that “no disease is so often
missed by experienced physicians”. It is true that a diag-
nosis is always based on and preceded by knowledge.
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